Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Psychedelic Opportunity You Need to Know About

When Stockhouse Editorial last caught up with Toronto-based CYBIN Inc. ( N.CYBN , OTC: CYBN , Forum ) back in September 2020 , the psychedelic life sciences company was just going public…and to much fanfare. Cybin is a life sciences company that views psychedelic subst...
Dave Jackson | October 19, 2021 |

A ‘Barrier’ to Better Health

(Click image to play podcast) The blood-brain barrier plays an essential role in protecting the brain from blood-borne disease. But is also one of medicine’s great paradoxes – a system designed to protect the most sensitive region of the body bu...
Dave Jackson | September 29, 2020 |

Buzz on the Bullboards: Stocks Poised for Coronavirus Recovery?

Where do small-cap investors look when the markets are down? Go back a few weeks or months and you’ll see that the COVID 19 coronavirus was being brushed off by Wall Street. Fast forward to last week, and it seems like the other shoe has finally dropped, se...
Omri Wallach | February 26, 2020 |

Baudax Shares Rise as FDA Approves NDA for Its Non-Opioid Pain Medication

Shares of Baudax Bio traded more than 20% higher and set a new 52-week high price after reporting that the FDA approved the company's non-opioid ANJESO™ drug for management of moderate to severe pain. Specialty pharmaceutical company Baudax Bio Inc. (BXRX:N...
Streetwise Reports | February 24, 2020 |

Understanding Fortress Biotech

Daniel Carlson of Tailwinds Research takes a close look at what he calls a "great value opportunity," with a focus on subsidiary Avenue Therapeutics. With a plethora of balls in the air, Fortress Biotech Inc. (FBIO:NASDAQ) is a very difficult company to va...
Streetwise Reports | February 6, 2020 |

Wounded Animals, Indeed

"The permabulls will tell you that the bullion banks and their treasury department conspirators have lost all power in this 'new paradigm' and we should relax and refrain from worry. I tend to disagree because wounded animals are the singular most dangerous of all creat...
Streetwise Reports | September 10, 2019 |

Explorer Set to Drill on 'Standout' Target in the Golden Triangle

The thing about experience is it lets you see current situations in context—opportunities are more apparent when you've gone through the experience before. Libero Copper Corp. (LBC:TSX.V:, LBCMF:OTCQB) was established in 2016 for exactly this reason. A group of geolo...
Streetwise Reports | August 22, 2019 |

Q&A with Bhang CEO Scott Van Rixel

Bhang Corporation , ( P.BHNG , Forum ) known best for the 8-time cannabis cup award-winning gourmet chocolate bar, is built on a tradition of innovation and trust that has wowed consumers over the last nine years and helped re-define the cannabis market today. Their un...
Dave Jackson | June 27, 2019 |